Related Articles
EphA2 receptor activation with ephrin-A1 ligand restores cetuximab efficacy in NRAS-mutant colorectal cancer cells
Efficacy of cetuximab‑based chemotherapy in metastatic colorectal cancer according to RAS and BRAF mutation subgroups: A meta‑analysis
Cetuximab retreatment in patients with metastatic colorectal cancer who exhibited a clinical benefit in response to prior cetuximab: A retrospective study
Bevacizumab-containing regimens after cetuximab failure in Kras wild-type metastatic colorectal carcinoma
EGFR methylation and outcome of patients with advanced colorectal cancer treated with cetuximab